drugset / Trial / NCT00206466

Biologic Correlative Taxotere/AC

NCT00206466 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

We are asking you to take part in a research study of biomarkers (characteristics or traits of the genes inside cancer cells). We want to learn if these biomarkers could help us learn how well your breast cancer may respond (improve) to chemotherapy (drugs to treat cancer).

Timeline

Start
2002-04
Primary completion
2006-04
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclophosphamide Other / unclassified 600 mg/m2 —
Comparator Docetaxel Small molecule 100 mg/m2 —
Comparator Doxorubicin Other / unclassified 60 mg/m2 —

Indications